Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.037 AUD | -7.50% |
|
-2.63% | -61.86% |
06-19 | Biotron's HIV Therapy Meets Primary Endpoints in Phase Two Trial; Shares Rally 15% | MT |
04-05 | Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25% | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michelle Miller
CEO | Chief Executive Officer | - | 20/06/02 |
Stephen Becker
CTO | Chief Tech/Sci/R&D Officer | - | 16/07/20 |
Corporate Secretary | 67 | 22/02/99 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Thomas
BRD | Director/Board Member | 79 | 06/03/12 |
Michael Hoy
CHM | Chairman | 75 | 06/02/00 |
Michelle Miller
CEO | Chief Executive Officer | - | 20/06/02 |
Susan Pond
BRD | Director/Board Member | - | 06/03/12 |
Director/Board Member | - | 22/10/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 901,944,902 | 724,063,389 ( 80.28 %) | 0 | 80.28 % |
Company contact information
![address Biotron Limited(BIT)](https://cdn.zonebourse.com/static/address/10353335.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-61.86% | 22.52M | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.56B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- BIT Stock
- Company Biotron Limited